Flossbach Von Storch SE Buys 44,490 Shares of Danaher Co. (NYSE:DHR)

Flossbach Von Storch SE raised its stake in shares of Danaher Co. (NYSE:DHR) by 1.2% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 3,710,738 shares of the conglomerate’s stock after purchasing an additional 44,490 shares during the period. Danaher accounts for about 3.4% of Flossbach Von Storch SE’s investment portfolio, making the stock its 11th biggest holding. Flossbach Von Storch SE owned approximately 0.51% of Danaher worth $851,800,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently made changes to their positions in DHR. FMR LLC grew its position in shares of Danaher by 15.8% during the third quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock worth $6,566,116,000 after purchasing an additional 3,217,631 shares in the last quarter. Van ECK Associates Corp boosted its stake in Danaher by 6,862.7% in the 4th quarter. Van ECK Associates Corp now owns 929,868 shares of the conglomerate’s stock worth $213,452,000 after purchasing an additional 916,513 shares during the period. Massachusetts Financial Services Co. MA grew its holdings in Danaher by 17.6% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock valued at $996,141,000 after buying an additional 535,254 shares in the last quarter. International Assets Investment Management LLC raised its position in shares of Danaher by 40,196.5% during the third quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock valued at $119,539,000 after buying an additional 428,897 shares during the last quarter. Finally, Montrusco Bolton Investments Inc. lifted its holdings in shares of Danaher by 30.4% in the third quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate’s stock worth $465,617,000 after buying an additional 397,671 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have issued reports on DHR. TD Cowen lifted their price target on shares of Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $277.00 target price (down from $299.00) on shares of Danaher in a report on Thursday, January 30th. UBS Group dropped their price target on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research note on Wednesday, October 23rd. Scotiabank initiated coverage on Danaher in a research note on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price objective on the stock. Finally, Robert W. Baird lowered their target price on Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Seven analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Price Performance

DHR opened at $205.23 on Thursday. The business has a fifty day moving average of $227.74 and a 200 day moving average of $247.80. The stock has a market cap of $148.24 billion, a P/E ratio of 38.87, a PEG ratio of 2.63 and a beta of 0.83. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70.

Danaher (NYSE:DHR) last issued its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the company earned $2.09 earnings per share. As a group, sell-side analysts anticipate that Danaher Co. will post 7.67 EPS for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.53%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s dividend payout ratio (DPR) is presently 20.45%.

Insider Activity

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 10.90% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.